Agios Pharmaceuticals, Inc.

AGIONASDAQ • USD
30.45 USD
↘ 1.14 (3.61%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Agios Pharmaceuticals, Inc. (AGIO) is currently trading at $30.45. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. AGIO is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$31.29
High?$32.78
Low?$30.40
Prev. Close?$31.59
Volume?165.6K
Avg. Volume?1.2M
VWAP?$30.99
Rel. Volume?0.13x
Bid / Ask
Bid?$30.43 × 100
Ask?$34.89 × 100
Spread?$4.46
Midpoint?$32.66
Valuation & Ratios
Market Cap?1.9B
Shares Out?59.8M
Float?56.5M
Float %?94.6%
P/E Ratio?N/A
P/B Ratio?1.93
EPS?-$6.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Employees
540
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-07-24
Address
88 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617-649-8600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
92
Short Sent.?
65
Piotroski F-Score?3/9Weak
Altman Z-Score?11.89Safe
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.55%High
Short Interest?6.5M
Days to Cover?5.2
Free Float56.5M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.69Strong
Quick Ratio?9.21Strong
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
76
1.93CHEAP▾
P/S?
Peers
100
S&P
3
13.41HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.3CHEAP▾
EV/Sales?
Peers
100
S&P
7
12.50HIGH▾
Returns & Efficiency
ROE?
S&P
3
-38.1%WEAK▾
ROA?
S&P
3
-35.1%WEAK▾
Cash Flow & Enterprise
FCF?$-335968000
Enterprise Value?$1.8B
Fundamentals ratios updated end of day